Novotney-Barry, Anna-Marie,Hulhoven, Reginald,Parker, Gerald L.,Hoskin, Violet A.
申请号：
AU2010294905
公开号：
AU2010294905A1
申请日:
2010.08.26
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The invention relates to the treatment of autoimmune or inflammatory disorders with antibodies to CD22. In particular, the invention relates to the treatment of autoimmune or inflammatory disorders with epratuzumab with a new dosing regimen. More particularly, the invention relates to the treatment of SLE.
